Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: l hip oa major surgical or invasive procedure: l thr history of present illness: m with l hip oa past medical history: htn gerd sinus node dysfunction --> ddd pacer (v-paced at 70) atrial fibrillation s/p cardioversion s/p orif "right leg" cholecystectomy cataract removal turp aortic stenosis s/p avr (st. porcine valve, ) carpal tunnel syndrome s/p release allergic rhinitis social history: mr. is a retired window cleaner. he quit smoking 20 years ago and reports having smoked 1.5 packs per day for sixty years. he estimates drinking about 3 alcoholic drinks per month. he lives alone. family history: mr. any contributory family history. physical exam: at the time of discharge: avss nad wound c/d/i without erythema /fhl/ta/gs intact silt distally pertinent results: 06:25am blood wbc-6.5 rbc-3.35* hgb-9.5* hct-28.5* mcv-85 mch-28.4 mchc-33.3 rdw-16.3* plt ct-257 06:35am blood wbc-6.7 rbc-3.26* hgb-9.6* hct-27.7* mcv-85 mch-29.4 mchc-34.6 rdw-16.0* plt ct-217 07:00am blood wbc-6.5 rbc-3.17* hgb-9.3* hct-27.5* mcv-87 mch-29.2 mchc-33.8 rdw-16.1* plt ct-196 04:36am blood wbc-7.1 rbc-3.15* hgb-9.1* hct-26.9* mcv-85 mch-28.9 mchc-33.9 rdw-15.9* plt ct-159 09:30pm blood hct-27.7* 04:34am blood wbc-7.4 rbc-3.00* hgb-8.5* hct-25.9* mcv-86 mch-28.5 mchc-33.0 rdw-15.6* plt ct-130* 04:30am blood wbc-10.5 rbc-3.54* hgb-10.0* hct-30.4* mcv-86 mch-28.1 mchc-32.7 rdw-15.6* plt ct-158 04:36am blood wbc-9.5# rbc-3.60*# hgb-10.3*# hct-31.1* mcv-86 mch-28.7 mchc-33.2 rdw-15.6* plt ct-159# 09:50pm blood hct-29.6*# 08:25pm blood wbc-6.2# rbc-2.37*# hgb-6.8*# hct-20.8*# mcv-88 mch-28.7 mchc-32.8 rdw-15.5 plt ct-105* 04:03pm blood wbc-12.8*# rbc-3.62* hgb-10.3* hct-31.3* mcv-86 mch-28.4 mchc-32.8 rdw-15.4 plt ct-163 04:34am blood neuts-79.9* lymphs-10.8* monos-5.8 eos-3.3 baso-0.2 06:25am blood plt ct-257 06:25am blood pt-33.3* ptt-38.4* inr(pt)-3.5* 06:35am blood plt ct-217 06:35am blood pt-33.1* ptt-39.7* inr(pt)-3.5* 09:20pm blood pt-33.0* ptt-43.2* inr(pt)-3.4* 07:00am blood plt ct-196 04:36am blood plt ct-159 09:20pm blood pt-33.0* ptt-43.2* inr(pt)-3.4* 07:00am blood plt ct-196 04:36am blood plt ct-159 04:36am blood pt-19.8* ptt-36.0* inr(pt)-1.8* 04:34am blood plt ct-130* 04:34am blood pt-17.6* ptt-35.9* inr(pt)-1.6* 04:30am blood plt ct-158 04:30am blood pt-16.3* inr(pt)-1.4* 04:36am blood plt ct-159# 04:36am blood pt-14.9* ptt-29.4 inr(pt)-1.3* 08:25pm blood plt ct-105* 08:25pm blood pt-16.3* ptt-35.1* inr(pt)-1.5* 04:03pm blood plt ct-163 06:25am blood glucose-92 urean-15 creat-0.9 na-137 k-3.8 cl-104 hco3-26 angap-11 06:35am blood glucose-92 urean-17 creat-0.8 na-139 k-3.8 cl-104 hco3-25 angap-14 07:00am blood glucose-89 urean-18 creat-0.7 na-137 k-3.8 cl-103 hco3-26 angap-12 04:36am blood glucose-95 urean-23* creat-0.8 na-138 k-3.4 cl-104 hco3-27 angap-10 04:34am blood glucose-100 urean-25* creat-0.8 na-137 k-3.9 cl-106 hco3-28 angap-7* 04:30am blood glucose-111* urean-22* creat-0.8 na-135 k-3.8 cl-102 hco3-29 angap-8 04:36am blood glucose-111* urean-23* creat-0.9 na-142 k-4.1 cl-108 hco3-25 angap-13 08:25pm blood glucose-93 urean-20 creat-0.9 na-138 k-4.1 cl-104 hco3-26 angap-12 04:03pm blood glucose-98 urean-23* creat-1.0 na-138 k-4.1 cl-106 hco3-25 angap-11 04:36am blood ck(cpk)-418* 04:36am blood ck-mb-6 ctropnt-0.03* 08:25pm blood ck-mb-5 ctropnt-0.02* 06:25am blood calcium-8.0* phos-3.1 mg-1.9 06:35am blood calcium-7.8* phos-2.9 mg-1.8 07:00am blood calcium-7.8* phos-2.4* mg-1.8 iron-17* 04:36am blood calcium-8.0* phos-1.9* mg-1.8 04:34am blood calcium-8.0* phos-1.8* mg-2.0 04:30am blood calcium-8.6 phos-2.5* mg-2.0 04:36am blood calcium-8.3* phos-3.4 mg-2.0 08:25pm blood calcium-8.2* phos-3.2 mg-1.7 04:03pm blood calcium-8.2* phos-3.3 mg-2.1 07:00am blood caltibc-226* vitb12-338 folate-11.0 ferritn-197 trf-174* brief hospital course: the patient was admitted on and, later that day, was taken to the operating room by dr. for l thr without complication. please see operative report for details. postoperatively the patient was hypotensive in the pacu and unresponsive to fluid boluses, albumin and intermittent neo boluses. the patient was transferred to the icu where he was maintained on a dopamine drip from until . he received a 1 unit transfusion on pod#1 for hct 25.9. on the patient was deemed safe for transfer to the floor where he continued to do well. he received iv antibiotics for 24 hours postoperatively, as well as coumadin for dvt prophylaxis. he received a lovenox bridge until his inr became therapeutic. his inr was 3.5 on so his coumadin dose was reduced to 4mg daily (from his usual home dose of 8mg daily). the drain was removed without incident on pod#1. the foley catheter was removed without incident on pod#5. the surgical dressing was removed on pod#2 and the surgical incision was found to be clean, dry, and intact without erythema or purulent drainage. while in the hospital, the patient was seen daily by physical therapy. labs were checked throughout the hospital course and repleted accordingly. at the time of discharge the patient was tolerating a regular diet and feeling well. the patient was afebrile with stable vital signs. the patient's hematocrit was stable, and the patient's pain was adequately controlled on a po regimen. the operative extremity was neurovascularly intact and the wound was benign. the patient was discharged to rehabilitation in a stable condition. medications on admission: digoxin 125mcg qd, lasix 20 qd, lisinopril 2.5 qd, omeprazole discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 2. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 3. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po daily (daily). 4. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day). 5. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily). 6. multivitamin tablet sig: one (1) tablet po daily (daily). 7. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 8. digoxin 125 mcg tablet sig: one (1) tablet po daily (daily). 9. enoxaparin 40 mg/0.4 ml syringe sig: one (1) syringe subcutaneous once a day for 3 weeks: to be followed by aspirin 325mg daily for 3 weeks. 10. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours). 11. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 12. warfarin 2 mg tablet sig: two (2) tablet po daily (daily): target inr 2-2.5. inr to be followed by rehab physician while at rehab followed by pcp dr (phone ) after discharge. 13. furosemide 20 mg tablet sig: one (1) tablet po daily (daily). 14. trazodone 50 mg tablet sig: 0.25 tablet po hs (at bedtime) as needed for insomnia. 15. oxycodone 5 mg tablet sig: 0.5 tablet po q4-6h () as needed for breakthrough pain. 16. levofloxacin 250 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 7 days: until . 17. lisinopril 5 mg tablet sig: 0.5 tablet po daily (daily). discharge disposition: extended care facility: nursing home - discharge diagnosis: l hip oa discharge condition: stable discharge instructions: weigh yourself every morning, md if weight > 3 lbs. adhere to 2 gm sodium diet experience severe pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers >101.5, shaking chills, redness or drainage from the incision site, chest pain, shortness of breath or any other concerns. 2. please follow up with your pcp regarding this admission and any new medications and refills. 3. resume your home medications unless otherwise instructed. 4. you have been given medications for pain control. please do not operate heavy machinery or drink alcohol when taking these medications. as your pain improves, please decrease the amount of pain medication. this medication can cause constipation, so you should drink plenty of water daily and take a stool softener (e.g., colace) as needed to prevent this side effect. 5. you may not drive a car until cleared to do so by your surgeon or your primary physician. 6. please keep your wounds clean. you may get the wound wet or take a shower starting 5 days after surgery, but no baths or swimming for at least 4 weeks. no dressing is needed if wound continues to be non-draining. any stitches or staples that need to be removed will be taken out by a visiting nurse at 2 weeks after your surgery. 7. please call your surgeon's office to schedule or confirm your follow-up appointment at 4 weeks. 8. please do not take any nsaids (i.e. celebrex, ibuprofen, advil, motrin, etc). 9. anticoagulation: please continue your lovenox for 3 weeks to prevent deep vein thrombosis (blood clots). after completing the lovenox, please take aspirin 325mg daily for an additional three weeks. 10. wound care: please keep your incision clean and dry. it is okay to shower after pod#5 but do not take a tub-bath or submerge your incision until 4 weeks after surgery. please place a dry sterile dressing on the wound each day if there is drainage, otherwise leave it open to air. check wound regularly for signs of infection such as redness or thick yellow drainage. staples will be removed by vna in 2 weeks. if you are going to rehab, the rehab facility can remove the staples at 2 weeks. 11. activity: weight bearing as tolerated on the operative leg, and cpm machine advancing as tolerated. no strenuous exercise or heavy lifting until follow up appointment. 12. vna (once at home): home pt/ot, dressing changes as instructed, wound checks, and staple removal at 2 weeks after surgery. physical therapy: wbat treatments frequency: wound checks. physical therapy. vna to remove staples at 2 weeks. lovenox injections. followup instructions: provider: , md phone: date/time: 3:40 provider: , : date/time: 9:20 cc: procedure: venous catheterization, not elsewhere classified total hip replacement diagnoses: other iatrogenic hypotension esophageal reflux urinary tract infection, site not specified congestive heart failure, unspecified unspecified essential hypertension acute posthemorrhagic anemia atrial fibrillation hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) systolic heart failure, unspecified cardiac pacemaker in situ heart valve replaced by transplant osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh hip joint replacement acute edema of lung, unspecified other specific disorders of sleep of nonorganic origin 

Answer: The patient is high likely exposed to